
|Articles|January 20, 2015
Covance Solution Bridges Preclinical to Clinical Development
Covance Inc., the world’s most comprehensive drug development company, today announced the introduction of Covance Early Phase Development Solutions,
Advertisement
Covance has introduced its Early Phase Development Solutions, a multi-disciplined approach to early drug development that provides sponsors access to a molecule solution team made up of experts from nonclinical, clinical and regulatory disciplines. These experts will focus on the sponsor’s unique target product profile to provide ongoing continuity in strategic program design that spans nonclinical through to first-in-human ready, Phase II ready, proof-of-concept and full-development ready.
Read the full text
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Patient Centricity: What Rare Disease Research Gets Right
2
AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective
3
Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal
4
FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data
5




